CellX launches China's first pilot plant for cultivated meat

Shanghai-based cell-grown meat start-up CellX launched China’s first cultivated meat pilot factory, a significant breakthrough in the nation’s quest for a sustainable source of animal protein to feed its population. The pilot plant represents a step closer to bringing cultivated meat to dining tables before large-scale production, Co-founder and CEO Ziliang Yang said. The plant has a 2,000 liter bioreactor with a capacity to produce “single-digit tons” of cultivated meat per year, Yang said, with more bioreactors to be added soon. “The insights from this pilot facility will be used for our commercial production facility that we are planning to complete by 2025, which will be able to produce hundreds of tons of products per year,” said Yang. In May 2022, Chinese authorities expressed their support for the development of synthetic protein as a food source to reduce the pressures on environmental resources brought on by traditional livestock breeding, as part of its 14th Five Year development plan for the bio-economy. This was preceded by the inclusion of lab-grown meat and other alternative proteins in January to ensure a sustainable food supply.

Yang said the pilot facility will help to reduce CellX’s production cost to below USD100 per pound, making it competitive against premium meats, he said, adding that the launch of CellX’s commercial production facility in 2025 will further reduce costs. In comparison, one pound of A5 grade Japanese Wagyu Kobe beef sells for around USD189 on Amazon. “The fact that we’re able to do pilots and reduce costs below USD100 per pound is really a major milestone that signifies the transition from R&D to production,” said Yang. “Industrialization and commercialization is something that we will focus on next.”

Later this year, CellX plans to approach food regulators in the U.S. and Singapore to approve its products for sale followed by other international markets in 2025. In June, the U.S. became the second country after Singapore to allow the sale of cultivated meat after Upside Foods and Good Meat received the go-ahead from the U.S. Department of Agriculture to sell lab-grown meat. Cultivated meat is produced by cultivating animal cells directly, eliminating the need to raise animals for food. Singapore allowed the sale of cultured meat in December 2020, when start-up Eat Just received approval to sell its laboratory-created chicken.

Founded in 2020, CellX has raised around USD20 million from four rounds of investment from strategic investors such as Joyvio Capital, which is backed by China’s Legend Holdings, and South Korean conglomerate SK Group. CellX signed a strategic partnership with Berlin-based Bluu Seafood in April 2022 to help both companies drive regulatory compliance and expand consumer acceptance of lab-grown protein products in the Chinese and European markets, the South China Morning Post reports.